BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Procognia Limited Signs Binding Letter of Intent with Beijing Cy-Tech for the Exclusive Marketing and Distribution of its GlycoScope™ Product in the Greater China Region


3/7/2012 7:05:21 AM

TEL-AVIV, Israel--(BUSINESS WIRE)--Procognia (TASE: PRCG), announced that, on Thursday March 1, it signed a binding letter of intent with Beijing Cy-Tech Biotech Company("Cy-Tech"), by which Cy-Tech was granted the exclusive rights to sell, distribute and market Procognia’s glycoanalysis product, the GlycoScopeTM ("the Product") in the Greater China Region (China, Hong Kong, Macao and Taiwan) ("the Territory"). In addition, Cy-Tech was awarded the exclusive right to provide its clients in the Territory with glycoanalytical services relying on knowhow and expertise that Cy-Tech will receive from the company ("the Services" and "the letter of intent"). Beyond the compensation that will be received by the company through the purchase of the Product by Cy-Tech, the company will be entitled to a certain percentage of the revenues received by Cy-Tech due to the provision of these services. Cy-Tech will be responsible for all sales and marketing activities related to the Product, and also for providing Services in the Territory, and will bear all costs associated with these services. Cy-Tech will also provide local technical support to its clients in the Territory with support from the company.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES